A Model for Irritable Bowel Syndrome and Anxiety Comorbidities in Relation to Alcohol Use Disorders

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2023 Jun 9

PMID 37293305

Authors

Katsiaryna Vashkevich

Kathryn Janiuk

Nasim Maleki

Affiliations

Soon will be listed here.

Abstract

About 95% of human body serotonin synthesis occurs in the gastrointestinal tract (GI). Lack of sufficient serotonin levels is thought to play a key role in mood disorders, including anxiety disorders. In this study, we looked at a disorder affecting the GI tract, irritable bowel syndrome (IBS), and aimed to determine whether IBS is differentially associated with anxiety disorders in 252 chronic pain patients in the presence of a history of alcohol use disorders (AUD) given that alcohol is an extremely aggressive substance for the GI mucosa. We found that while the prevalence of IBS was not affected by the presence of AUD in chronic pain patients, IBS had significantly higher comorbidity with anxiety disorders in chronic pain patients with comorbid alcohol use disorders. We argue that these findings highlight mechanistic differences in the comorbidity of anxiety disorders with chronic pain and AUD, implicating a central role for GI problems stemming from chronic alcohol use. The findings may have important implications for the treatment of IBS patients with AUD who commonly present with anxiety disorders which could motivate the continuation of problematic drinking and impede recovery success. We propose that addressing GI problems in patients with AUD may help manage AUD and recovery more effectively.

References

Chang L . The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011; 140(3):761-5. PMC: 3039211. DOI: 10.1053/j.gastro.2011.01.032. View

Martin E, Ressler K, Binder E, Nemeroff C . The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am. 2009; 32(3):549-75. PMC: 3684250. DOI: 10.1016/j.psc.2009.05.004. View

Atkinson W, Lockhart S, Whorwell P, Keevil B, Houghton L . Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2006; 130(1):34-43. DOI: 10.1053/j.gastro.2005.09.031. View

Lydiard R . The role of GABA in anxiety disorders. J Clin Psychiatry. 2003; 64 Suppl 3:21-7. View

Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M . Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology. 2005; 31(4):739-50. DOI: 10.1038/sj.npp.1300858. View

Rendon J, Li X, Akhtar S, Choudhry M . Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury. Shock. 2012; 39(1):11-8. PMC: 3526677. DOI: 10.1097/SHK.0b013e3182749f96. View

Dunlop S, Coleman N, Blackshaw E, Perkins A, Singh G, Marsden C . Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005; 3(4):349-57. DOI: 10.1016/s1542-3565(04)00726-8. View

Grover M, Kolla B, Pamarthy R, Mansukhani M, Breen-Lyles M, He J . Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults. PLoS One. 2021; 16(1):e0245323. PMC: 7808669. DOI: 10.1371/journal.pone.0245323. View

Nautiyal K, Ribeiro A, Pfaff D, Silver R . Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci U S A. 2008; 105(46):18053-7. PMC: 2584714. DOI: 10.1073/pnas.0809479105. View

10.

Gros M, Gros B, Mesonero J, Latorre E . Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med. 2021; 10(15). PMC: 8347293. DOI: 10.3390/jcm10153429. View

11.

Tran H, Gupta M, Gupta K . Targeting novel mechanisms of pain in sickle cell disease. Blood. 2017; 130(22):2377-2385. PMC: 5709786. DOI: 10.1182/blood-2017-05-782003. View

12.

Cataldo G, Rajput S, Gupta K, Simone D . Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease. Pain. 2015; 156(4):722-730. PMC: 4366346. DOI: 10.1097/j.pain.0000000000000104. View

13.

Kennedy P, Cryan J, Dinan T, Clarke G . Irritable bowel syndrome: a microbiome-gut-brain axis disorder?. World J Gastroenterol. 2014; 20(39):14105-25. PMC: 4202342. DOI: 10.3748/wjg.v20.i39.14105. View

14.

Guo Y, Zhuang K, Kuang L, Zhan Q, Wang X, Liu S . Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver. 2014; 9(5):649-56. PMC: 4562783. DOI: 10.5009/gnl13437. View

15.

Holtmann G, Ford A, Talley N . Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2017; 1(2):133-146. DOI: 10.1016/S2468-1253(16)30023-1. View

16.

Theoharides T, Tsilioni I, Bawazeer M . Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front Cell Neurosci. 2019; 13:353. PMC: 6687840. DOI: 10.3389/fncel.2019.00353. View

17.

Clapp P, Bhave S, Hoffman P . How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health. 2010; 31(4):310-39. PMC: 2923844. View

18.

Turner S, Mota N, Bolton J, Sareen J . Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depress Anxiety. 2018; 35(9):851-860. PMC: 6175215. DOI: 10.1002/da.22771. View

19.

Kirsch R, Kirsch R, Riddell R, Riddell R . Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006; 19(12):1638-45. DOI: 10.1038/modpathol.3800704. View

20.

Anker J, Kushner M . Co-Occurring Alcohol Use Disorder and Anxiety: Bridging Psychiatric, Psychological, and Neurobiological Perspectives. Alcohol Res. 2019; 40(1). PMC: 6927748. DOI: 10.35946/arcr.v40.1.03. View